Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $113.28 million versus the consensus estimate of $115.32 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.